Please use this identifier to cite or link to this item:
                
    
    192.168.6.56/handle/123456789/45282Full metadata record
| DC Field | Value | Language | 
|---|---|---|
| dc.contributor.editor | Wiley, John | - | 
| dc.date.accessioned | 2019-02-19T08:51:39Z | - | 
| dc.date.available | 2019-02-19T08:51:39Z | - | 
| dc.date.issued | 2000 | - | 
| dc.identifier.isbn | 0-471-62744-5 | - | 
| dc.identifier.uri | http://10.6.20.12:80/handle/123456789/45282 | - | 
| dc.language.iso | en | en_US | 
| dc.publisher | John Wiley & Sons, Inc | en_US | 
| dc.subject | Pharmacogenetics ^Congresses | en_US | 
| dc.title | From Genome To Therapy: Integrating New Technologies With Drug Development | en_US | 
| dc.type | Book | en_US | 
| Appears in Collections: | Medicine | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
